Cardiovascular Systems In... (CSII)
NASDAQ: CSII
· Real-Time Price · USD
20.00
0.03 (0.15%)
At close: Apr 27, 2023, 10:00 PM
Cardiovascular Systems Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 61.45M | 59.67M | 62.5M | 56.22M | 59.13M | 58.37M | 70.99M | 63.27M | 64.17M | 60.54M |
Cost of Revenue | 18.46M | 16.7M | 16.27M | 14.79M | 18.07M | 14.31M | 20.63M | 14.01M | 13.92M | 12.56M |
Gross Profit | 42.99M | 42.98M | 46.23M | 41.43M | 41.06M | 44.06M | 50.35M | 49.26M | 50.25M | 47.98M |
Operating Income | -8.53M | -10.9M | -9.48M | -9.65M | -8.56M | -8.12M | -4.91M | -5.65M | 283K | -1.66M |
Interest Income | 1.09M | 658K | 250K | 460K | 64K | 43K | 99K | 120K | 136K | 144K |
Pretax Income | -7.84M | -10.65M | -9.64M | -9.6M | -8.9M | -8.48M | -5.22M | -5.94M | 7K | -2.01M |
Net Income | -7.89M | -10.63M | -9.69M | -9.66M | -8.97M | -8.62M | -5.29M | -6M | -56K | -2.08M |
Selling & General & Admin | 41.64M | 44.48M | 46.59M | 41.68M | 40.4M | 41.85M | 45.71M | 41.44M | 40.06M | 40.28M |
Research & Development | 9.53M | 9.06M | 8.77M | 9.05M | 8.87M | 10.02M | 9.24M | 13.16M | 9.6M | 9.05M |
Other Expenses | 345K | 346K | 346K | 346K | 346K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 51.52M | 53.88M | 55.71M | 51.08M | 49.62M | 52.18M | 55.26M | 54.91M | 49.97M | 49.64M |
Interest Expense | 404K | 406K | 407K | 408K | 409K | 410K | 412K | 412K | 412K | 499K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 69.98M | 70.58M | 71.98M | 65.87M | 67.69M | 66.48M | 75.9M | 68.92M | 63.89M | 62.2M |
Income Tax Expense | 49K | -19K | 48K | 63K | 63K | 136K | 63K | 63K | 63K | 63K |
Shares Outstanding (Basic) | 39.66M | 39.61M | 39.35M | 39.29M | 39.2M | 39.09M | 38.93M | 38.91M | 38.81M | 38.68M |
Shares Outstanding (Diluted) | 39.66M | 39.61M | 39.35M | 39.29M | 39.2M | 39.09M | 38.93M | 38.91M | 38.81M | 38.68M |
EPS (Basic) | -0.2 | -0.27 | -0.25 | -0.25 | -0.23 | -0.22 | -0.14 | -0.15 | -0.00 | -0.05 |
EPS (Diluted) | -0.2 | -0.27 | -0.25 | -0.25 | -0.23 | -0.22 | -0.14 | -0.15 | -0.00 | -0.05 |
EBITDA | -8.18M | -9.02M | -9.14M | -9.3M | -7.21M | -6.81M | -4.61M | -4.47M | 1.48M | -1.35M |
EBIT | -7.43M | -10.24M | -9.23M | -9.19M | -8.49M | -8.07M | -4.81M | -5.53M | 419K | -1.51M |
Depreciation & Amortization | 345K | 1.88M | 346K | 346K | 1.35M | 1.26M | 304K | 1.06M | 1.06M | 304K |